Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

by Hayashi, N, Okanoue, T, Tsubouchi, H, Toyota, J, Chayama, K, Kumada, H
Published 2012

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

by Karino, Y, Ozeki, I, Hige, S, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J
Published 2014

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b

by Toyota, J, Ozeki, I, Karino, Y, Asahina, Y, Izumi, N, Takahashi, S, Kawakami, Y, Chayama, K, Kamiya, N, Aoki, K, Yamada, I, Suzuki, Y, Suzuki, F, Kumada, H
Published 2013